Company News

BASF Invests in 3Helix To Commercialize Collagen-Hybridizing Peptides for Personal Care

Equity investment and licensing agreement for the biotech start-up’s proprietary CHP technology.

Author Image

By: Christine Esposito

Editor-in-Chief

BASF and 3Helix Inc., a US-based technology start-up, have formed a partnership on 3Helix’s proprietary CHP technology. The partnership involves an equity investment and licensing agreement, granting BASF exclusive rights to commercialize CHP solutions for the personal care field.

3Helix's patented CHP technology is based on short, single-stranded collagen-like peptides that have the unique ability to bind to damaged and denatured collagen, enabling extraordinary anti-aging claims.

The partnership comes after successful R&D work by 3Helix, which has seen its CHP technology quickly progress from laboratory scale to pilot stage. Recognizing the immense potential of this technology, BASF says it plans to bring it in-house and aims to launch initial CHP solutions in 2025.

Since its establishment in 2015, 3Helix has focused on developing an innovative technology platform to target damaged collagen for various applications, including personal care.

“It has been an exciting journey to bring our technology to this point where we can partner with BASF,” states Mike Kirkness, CEO of 3Helix Inc., which is based in Salt Lake City, UT. “We look forward to the intense collaboration in the coming years and welcome BASF to the 3Helix board of directors.”

“With this partnership, BASF continues to demonstrate our investment in open innovation and expand our innovative offerings to our customers,” said Dr. Marina Safont Sempere, director of new business models and digital officer, Care Chemicals at BASF. “3Helix’s results from laboratory trials are very encouraging and show the potential of this new innovation for the personal care market.”

3Helix’s CHP Technology

3Helix’s Collagen Hybridizing Peptide (CHP) technology is the first platform that takes advantage of the difference in the 3D structure between damaged and healthy collagen, allowing CHPs to target, localize and bind to areas with damage. The next generation of the technology, bioACTIVE CHPs, are said to naturally activate the body’s rejuvenation mechanisms to provide younger, healthier looking skin, and even prevent skin aging.

Keep Up With Our Content. Subscribe To Happi Newsletters